Xu Jian, Shao Zhen, Li Dan, Xie Huafeng, Kim Woojin, Huang Jialiang, Taylor Jordan E, Pinello Luca, Glass Kimberly, Jaffe Jacob D, Yuan Guo-Cheng, Orkin Stuart H
Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
Children's Research Institute, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Mol Cell. 2015 Jan 22;57(2):304-316. doi: 10.1016/j.molcel.2014.12.009. Epub 2015 Jan 8.
Polycomb repressive complex 2 (PRC2) plays crucial roles in transcriptional regulation and stem cell development. However, the context-specific functions associated with alternative subunits remain largely unexplored. Here we show that the related enzymatic subunits EZH1 and EZH2 undergo an expression switch during blood cell development. An erythroid-specific enhancer mediates transcriptional activation of EZH1, and a switch from GATA2 to GATA1 controls the developmental EZH1/2 switch by differential association with EZH1 enhancers. We further examine the in vivo stoichiometry of the PRC2 complexes by quantitative proteomics and reveal the existence of an EZH1-SUZ12 subcomplex lacking EED. EZH1 together with SUZ12 form a non-canonical PRC2 complex, occupy active chromatin, and positively regulate gene expression. Loss of EZH2 expression leads to repositioning of EZH1 to EZH2 targets. Thus, the lineage- and developmental stage-specific regulation of PRC2 subunit composition leads to a switch from canonical silencing to non-canonical functions during blood stem cell specification.
多梳抑制复合物2(PRC2)在转录调控和干细胞发育中发挥着关键作用。然而,与替代亚基相关的特定背景功能在很大程度上仍未得到探索。在此,我们表明相关的酶亚基EZH1和EZH2在血细胞发育过程中经历表达转换。一个红细胞特异性增强子介导EZH1的转录激活,并且从GATA2到GATA1的转换通过与EZH1增强子的差异结合来控制发育过程中的EZH1/2转换。我们通过定量蛋白质组学进一步研究了PRC2复合物在体内的化学计量,并揭示了一种缺乏EED的EZH1 - SUZ12亚复合物的存在。EZH1与SUZ12一起形成一种非经典的PRC2复合物,占据活性染色质,并正向调控基因表达。EZH2表达缺失导致EZH1重新定位到EZH2的靶点。因此,PRC2亚基组成的谱系和发育阶段特异性调控导致在造血干细胞特化过程中从经典的沉默功能转换为非经典功能。